Deal would cap tumultuous run for retailer whose market value shrank from a peak of over $100 billion to below $8 billion.

The struggling pharmacy chain has already provided some clues to which parts of the business a new owner may want off the books.

The New York-based private equity firm has been having ongoing discussions about a deal to take Walgreens private, according to people familiar with the matter.